CLINICAL_TRIALS
trial_result
· 2024-12-12
Clinical Trial Update: Post-marketing Study Focused on Evaluating I+Med's DayDrop for Improving Signs and Symptoms of Mild/Moderate Dry Eye [NA]
Summary
Post-marketing study evaluating DayDrop for improving signs and symptoms of mild to moderate dry eye has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: i+Med S.Coop. | Conditions: Dry Eye, Dry Eye Syndrome (DES) | NA | Status: COMPLETED